TP53 and hepatocellular carcinoma: Topological analysis of PPI network indicated that TP53, STAT3, MDM2, HIF1A, ESR1, ERBB3, EGFR, CDKN1A, and CCND1 were the key anti-HCC targets in RGLD (Figure 3(b)) [39].